The US Federal Trade Commission (FTC) has sued to block GTCR’s proposed $627m merger-acquisition of critical medical device ...
Axios on MSN3h
FTC sues to block medical device coatings dealThe Federal Trade Commission under President Trump is making its first move to challenge private equity in health care, by ...
The regulator says the proposed merger would give the combined company more than 50% of the market for a type of medical ...
Surmodics (NASDAQ:SRDX) fell 4.6% after the Federal Trade Commission filed a lawsuit to block its planned $627 million sale ...
Surmodics, Inc. (Nasdaq: SRDX), a provider of medical device and in vitro diagnostic technologies to the healthcare industry, ...
The Federal Trade Commission on March 6 sued to block GTCR’ s acquisition of Surmodics, alleging that “the deal, which seeks to combine the two largest manufacturers of critical medical device ...
The regulator said the buyout “would lead to a highly concentrated market for outsourced hydrophilic coatings and eliminate ...
The FTC said merging Surmodics with Biocoat, where GTCR has a majority stake, would result in one company with more than 50% ...
WASHINGTON (Reuters) - The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' ...
Suppose a company is subject to personal jurisdiction in one state and is owned or subject to a controlling interest by an ...
The Federal Trade Commission announced it has sued to block GTCR BC Holdings’ acquisition of Surmodics (SRDX), alleging that the deal, which ...
The agency is challenging the deal, citing antitrust concerns due to GTCR's existing ownership of Surmodics' rival Biocoat.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback